Demonstrative research of clinical pathway to establish, implement and evaluate a clinical pathway (integrated Chinese and Western medicine) for cervical spondylotic radiculopathy (CSR)

General technical research on Clinical Directions to find the best Chinese Medicine diagnosis and treatment plan based on seven Sole sickness type including Diabetes Disease peripheral nerve pathologi

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-09000517

Enrollment

Unknown

Registered

2009-08-30

Start date

2009-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylotic radiculopathy (CSR)

Interventions

Group A:Review investigation cases

Group B:Clinical pathway treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were in accordance with diagnosis standard of CSR; 2. Agree to be a participant of the study; 3. Aged between 18 and 65.

Exclusion criteria

Exclusion criteria: 1. combined with mental illness, malignant tumor. 2. poor compliance,poor follow-up person. 3. there are indications for surgery; Caused by Main center pathological change, for example: Blood vessel of brain accident, blood or vessel diseases, etc..

Design outcomes

Primary

Measure	Time frame
Visual analog score for pain;Japanese Orthopedic Association (JOA) score for Cervical Radiculopathy;	—

Secondary

Measure	Time frame
hospitalization costs;hospitalization;	—

Countries

China

Contacts

Public ContactBolai Chen

tiger728@126.com+86 020 81887233-33029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026